FDA Approves TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE — Trigen Laboratories, LLC

Trigen Laboratories, LLC has secured FDA approval for its generic version of TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE, the moisture-sensitive, oral formulation previously marketed by Corphia Pharma. This approval grants Trigen entry into the market for a high-revenue pain management category, intensifying competitive pressure on brand competitors.